Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia
NCT00002414 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give CPI-1189 to patients with AIDS dementia.
Advanced HIV infection can cause AIDS dementia (brain damage due to HIV leading to loss of memory and muscle control). CPI-1189 may be able to postpone AIDS dementia or slow it down.
Conditions
- HIV Infections
Interventions
- DRUG
-
CPI-1189
Sponsors & Collaborators
-
Centaur Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Clifford DB
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828 ·Status: COMPLETED ·Phase: PHASE2
-
HIV Medication Adherence in Underserved Populations
NCT02392884 ·Status: UNKNOWN ·Phase: NA
-
A Study of Decreased Mental Function Associated With HIV
NCT00027040 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
NCT01340950 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
NCT00000709 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
NCT00000392 ·Status: COMPLETED ·Phase: PHASE2
-
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
NCT01108679 ·Status: COMPLETED
-
Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange
NCT05571761 ·Status: WITHDRAWN ·Phase: NA
-
Thinking and Memory Problems in People With HIV
NCT01875588 ·Status: RECRUITING
-
The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
NCT00002288 ·Status: COMPLETED ·Phase: NA
-
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
NCT03239899 ·Status: COMPLETED ·Phase: PHASE1
-
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy
NCT04266002 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucocorticoids on Cognition in HIV-infected Women
NCT03237689 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
NCT00000393 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Anti-HIV Therapy on Nervous System Function
NCT00432003 ·Status: COMPLETED
-
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
NCT00987948 ·Status: COMPLETED ·Phase: PHASE2
-
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
NCT01665846 ·Status: COMPLETED ·Phase: PHASE1
-
Research on the Psychological Status of Patients With HIV-1 Infection
NCT07080138 ·Status: NOT_YET_RECRUITING
-
Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS
NCT00118378 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
NCT00001048 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens
NCT00053443 ·Status: COMPLETED ·Phase: PHASE2
-
Neurobehavioral Model of HIV in Injection Drug Users
NCT00198861 ·Status: COMPLETED
-
Mild Neurocognitive Disorder in HIV Infection of the Brain
NCT01547754 ·Status: TERMINATED